These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 9712181)

  • 1. Regulation of the action of the novel cholecystokinin-releasing peptide diazepam binding inhibitor by inhibitory hormones and taurocholate.
    Herzig KH; Wilgus C; Schön I; Tatemoto K; Fölsch UR
    Regul Pept; 1998 Jun; 74(2-3):193-8. PubMed ID: 9712181
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diazepam binding inhibitor is a potent cholecystokinin-releasing peptide in the intestine.
    Herzig KH; Schön I; Tatemoto K; Ohe Y; Li Y; Fölsch UR; Owyang C
    Proc Natl Acad Sci U S A; 1996 Jul; 93(15):7927-32. PubMed ID: 8755579
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Somatostatin inhibits CCK release by inhibiting secretion and action of CCK-releasing peptide.
    Herzig KH; Louie DS; Owyang C
    Am J Physiol; 1994 Jun; 266(6 Pt 1):G1156-61. PubMed ID: 7517637
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diazepam-binding inhibitor mediates feedback regulation of pancreatic secretion and postprandial release of cholecystokinin.
    Li Y; Hao Y; Owyang C
    J Clin Invest; 2000 Feb; 105(3):351-9. PubMed ID: 10675361
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diazepam-binding inhibitor33-50 elicits Ca2+ oscillation and CCK secretion in STC-1 cells via L-type Ca2+ channels.
    Yoshida H; Tsunoda Y; Owyang C
    Am J Physiol; 1999 Mar; 276(3):G694-702. PubMed ID: 10070046
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of taurocholate on CCK release and pancreatic secretion produced by two CCK-releasing peptides in conscious rats.
    Miyasaka K; Funakoshi A; Shikado F; Uda K; Kitani K
    Pancreas; 1992; 7(5):536-42. PubMed ID: 1513801
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PYY potently inhibits pancreatic exocrine secretion mediated through CCK-secretin-stimulated pathways but not 2-DG-stimulated pathways in awake rats.
    Deng X; Guarita DR; Wood PG; Kriess C; Whitcomb DC
    Dig Dis Sci; 2001 Jan; 46(1):156-65. PubMed ID: 11270780
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of cholecystokinin secretion by food, hormones, and neural pathways in the rat.
    Lewis LD; Williams JA
    Am J Physiol; 1990 Apr; 258(4 Pt 1):G512-8. PubMed ID: 1970707
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endogenous somatostatin inhibits interaction of insulin and cholecystokinin on exocrine secretion of isolated, perfused rat pancreas.
    Park HS; Yoon HS; Park YD; Cui ZY; Lee YL; Park HJ
    Pancreas; 2002 May; 24(4):373-9. PubMed ID: 11961490
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intracolonic infusion of bile salt stimulates release of peptide YY and inhibits cholecystokinin-stimulated pancreatic exocrine secretion in conscious dogs.
    Izukura M; Hashimoto T; Gomez G; Uchida T; Greeley GH; Thompson JC
    Pancreas; 1991 Jul; 6(4):427-32. PubMed ID: 1876599
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CCK-releasing activity of rat intestinal secretion: effect of atropine and comparison with monitor peptide.
    Guan D; Ohta H; Tawil T; Liddle RA; Green GM
    Pancreas; 1990 Nov; 5(6):677-84. PubMed ID: 2281081
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Somatostatin is released in response to cholecystokinin by activation of type A CCK receptors.
    Lloyd KC; Maxwell V; Chuang CN; Wong HC; Soll AH; Walsh JH
    Peptides; 1994; 15(2):223-7. PubMed ID: 7911992
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cholecystokinin type A receptors mediate intestinal fat-induced inhibition of acid secretion through somatostatin-14 in dogs.
    Fung L; Pokol-Daniel S; Greenberg GR
    Endocrinology; 1994 Jun; 134(6):2376-82. PubMed ID: 7910794
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Somatostatin regulates duodenal cholecystokinin and somatostatin messenger RNA.
    Kanayama S; Liddle RA
    Am J Physiol; 1990 Mar; 258(3 Pt 1):G358-64. PubMed ID: 1969232
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cholecystokinin inhibits gastric acid secretion through type "A" cholecystokinin receptors and somatostatin in rats.
    Lloyd KC; Raybould HE; Walsh JH
    Am J Physiol; 1992 Sep; 263(3 Pt 1):G287-92. PubMed ID: 1357976
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Purification and characterization of a luminal cholecystokinin-releasing factor from rat intestinal secretion.
    Spannagel AW; Green GM; Guan D; Liddle RA; Faull K; Reeve JR
    Proc Natl Acad Sci U S A; 1996 Apr; 93(9):4415-20. PubMed ID: 8633081
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of calcium in monitor peptide-stimulated cholecystokinin release from perifused intestinal cells.
    Bouras EP; Misukonis MA; Liddle RA
    Am J Physiol; 1992 May; 262(5 Pt 1):G791-6. PubMed ID: 1590389
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Red kidney bean lectin is a potent cholecystokinin releasing stimulus in the rat inducing pancreatic growth.
    Herzig KH; Bardocz S; Grant G; Nustede R; Fölsch UR; Pusztai A
    Gut; 1997 Sep; 41(3):333-8. PubMed ID: 9378388
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Importance of cholecystokinin in peptide-YY release in response to pancreatic juice diversion.
    Guan D; Rivard N; Maouyo D; Gettys TW; Morisset J
    Regul Pept; 1993 Feb; 43(3):169-76. PubMed ID: 8441822
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Postprandial peptide YY release is mediated by cholecystokinin.
    McFadden DW; Rudnicki M; Kuvshinoff B; Fischer JE
    Surg Gynecol Obstet; 1992 Aug; 175(2):145-50. PubMed ID: 1636140
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.